Inventor · disambiguated record
Markus Ollert
Also filed as: OLLERT MARKUS · OLLERT MARKUS W · OLLERT MARKUS WOLFGANG
2 granted patents·11 pending applications·7 citations·filing 1993–2022
53Inventor score
Files withPLS DESIGN GMBH5LUXEMBOURG INST OF HEALTH LIH3BREDEHORST REINHARD2HELMOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT AND UMWELT GMBH1TOLEROGENICS S A R L1
Top patents by PatentIndex Score
13 records- 0179US10238735B2Controlled activation of complement components for use as endogenous adjuvantPLS DESIGN GMBH·Filed 2013·Granted Mar 26, 2019·3 cites·15 claims
- 0267US2022273791A1Selective local inhibition of tnfr1-mediated functions at the site of antigen/allergen presentationBREDEHORST REINHARD·Filed 2021·Application pending·0 cites
- 0355US2014178474A1Selective local inhibition of tnfr1-mediated functions at the site of antigen/allergen presentationPLS DESIGN GMBH·Filed 2013·Application pending·0 cites
- 0452US2019282692A1Selective local inhibition of tnfr1-mediated functions at the site of antigen/allergen presentationBREDEHORST REINHARD·Filed 2018·Application pending·0 cites
- 0548US2024307524A1Coronavirus vaccinesLUXEMBOURG INST OF HEALTH LIH·Filed 2022·Application pending·0 cites
- 0647US2016271257A1Low Molecular Weight Immune-Modulators As Adjuvants for Specific ImmunotherapyPLS-DESIGN GMBH·Filed 2014·Application pending·0 cites
- 0747US2017072048A1Selective local inhibition of tnfr1-mediated functions at the site of antigen/allergen presentationPLS-DESIGN GMBH·Filed 2015·Application pending·0 cites
- 0845US2013337044A1Modulation of effector t cell responses by local depletion of complement component c3PLS DESIGN GMBH·Filed 2013·Application pending·0 cites
- 0945US2022370605A1Inhibitor of DJ-1 for Use in Treating ImmunoagingLUXEMBOURG INST OF HEALTH LIH·Filed 2020·Application pending·0 cites
- 1035US2018085452A1Matrix-embedded tolerance-promoting adjuvants for subcutaneous immunotherapyTOLEROGENICS S A R L·Filed 2017·Application pending·0 cites
- 1134US5714344AProtease-derivatized CVFUNIV GEORGETOWN·Filed 1993·Granted Feb 3, 1998·4 cites·31 claims
- 1232US2022348667A1Specific ACKR2 Modulators for Use in TherapyLUXEMBOURG INST OF HEALTH LIH·Filed 2020·Application pending·0 cites
- 1329US2019083609A1Tofacitinib as vaccination immune modulatorHELMOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT AND UMWELT GMBH·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Ollert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →